Pinatuzumab (Anti-Siglec-2 / CD22)Pinatuzumab (Anti-Siglec-2 / CD22)
Move your mouse over image or click to enlarge

Pinatuzumab (Anti-Siglec-2 / CD22)

Pinatuzumab (Anti-Siglec-2 / CD22)a humanized IgG1 monoclonal antibody targeting CD22. It has potential antineoplastic activity and can be used in research of Non-Hodgkin Lymphoma. MW : 146.64 KD.
Cat# Size Price Qty Buy
A3059-1mg*25 1mg*25
£4,152.00
A3059-1mg*5 1mg*5
£1,384.00
A3059-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3059

Related Documents